Pediatric TB Management under RNTCP: What and Why?

Area of Science:

• Pediatrics
• Infectious Diseases
• Public Health

Background:

• Childhood tuberculosis is under-recognized in both general and specialized services.
• Diagnosing childhood TB is difficult due to inadequate samples and low smear sensitivity.
• Overlapping symptoms complicate early and accurate case detection in the community.

Purpose of the Study:

• To discuss the evolution and current status of diagnostics and therapy for childhood tuberculosis.
• To highlight the impact of newer diagnostic methods on TB detection and drug resistance.
• To review changes in TB treatment regimens and drug dosages.

Main Methods:

• Review of newer diagnostic methods: Cartridge-Based Nucleic Acid Amplification Tests (CBNAAT) and Line Probe Assays (LPA).
• Discussion of Revised National Tuberculosis Control Programme (RNTCP) guidelines for diagnostics and treatment.
• Analysis of changes in anti-TB drug dosages and fixed-drug combinations.
• Examination of updated treatment strategies based on drug resistance patterns.

Main Results:

• CBNAAT and LPA offer rapid and sensitive detection of Mycobacterium tuberculosis and Rifampicin resistance.
• Universal drug sensitivity testing (U-DST) is crucial for preventing the spread of drug-resistant TB.
• Revised upward dosages of anti-TB drugs and fixed-drug combinations enhance treatment efficacy.
• Addition of Ethambutol to the continuation phase addresses Isoniazid resistance.
• Replacement of Category II therapy with resistance-guided specific therapy.

Conclusions:

• Advancements in diagnostics and therapeutics have significantly improved childhood TB management.
• Accurate microbiological confirmation using quality specimens is vital for effective TB diagnosis.
• Tailoring treatment based on drug resistance patterns is essential for successful TB control.
• Continuous evolution of TB control strategies is necessary to combat the disease effectively.